Conditioning Regimens Including High-Dose Busulfan Cause a High Incidence of Transplant-Related Mortality after Myeloablative Stem Cell Transplantation

Publisher： Karger

E-ISSN： 1421-9794|50|4|178-183

ISSN： 0009-3157

Source： Chemotherapy, Vol.50, Iss.4, 2004-10, pp. : 178-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy without Stem Cell Transplantation for Refractory Childhood Systemic Lupus Erythematosus

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 331-335

Karger

Access to resources Recommend Favorite

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

High-Dose Ibuprofen in Cystic Fibrosis

By Lands Larry C.   Dauletbaev Nurlan  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2213-2224

MDPI

Access to resources Recommend Favorite

High-Dose Topical Bevacizumab for Corneal Neovascularization

By  

Pharmacology, Vol. 92, Iss. 5-6, 2013-12 ,pp. : 310-314

Karger

Access to resources Recommend Favorite

Extravasation of High‐Dose Methotrexate A Case about Nothing

By  

The Australian Journal of Hospital Pharmacy, Vol. 28, Iss. 6, 1998-12 ,pp. : 430-431

John Wiley & Sons Inc

Access to resources Recommend Favorite